stockrow
Friday 6 November 2026
Export AKTX’s income statement to Excel — free account
Akari Therapeutics PLC
AKTX Healthcare Biotechnology
- EPS
- −11.4%
- Free cash flow
- +4.51%
- Total debt
- −1.00%
Quarter to June 2026, against a year earlier
7.95
0.20
+2.58%
Follow AKTX
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.44 | 0.15 | 0.95 | 1.15 | 1.91 | 2.79 | 1.00 | 1.52 | 2.43 | 3.90 |
Net Debt/EBITDA |
0.27 | 0.09 | 0.23 | 0.57 | 0.54 | 0.78 | 0.15 | 0.18 | 0.74 | 1.62 |
Debt/Assets |
1.41% | 1.38% | 0.00% | 0.00% | 0.00% | 0.00% | 48.10% | 22.95% | 0.00% | 0.00% |
Debt/Equity |
0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 410.12 | 0.59 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.61 | 0.63 | 1.64 | 1.21 | 1.08 | 0.99 | 0.77 | 1.37 | 0.89 | 1.36 |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.87) | (1.37) |
Interest Coverage |
(18.20) | (88.70) | — | (503.01) | (1,623.97) | (1,322.13) | (3,084.20) | (89.93) | (215.42) | (191.07) |
| (68.43%) | (179.92%) | (1,281.43%) | (483.23%) | (233.27%) | (363.75%) | (1,080.27%) | (162.51%) | (138.13%) | (43.81%) | |
| (35.14%) | (72.08%) | (110.06%) | (139.31%) | (132.74%) | (162.03%) | (232.21%) | (88.82%) | (94.49%) | (31.34%) | |
ROIC |
(45.48%) | (66.73%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
251.10% | 116.71% | 4,118.52% | (1,000.45%) | (314.99%) | (182.55%) | 74,872.00% | (644.14%) | (207.98%) | (53.39%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.89 | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(12.56) | (42.04) | (134.25) | (275.34) | (350.96) | (429.12) | (564.12) | (1,169.96) | (2,027.92) | (1,678.86) |
Cash per Share |
6.25 | 8.90 | 31.41 | 169.65 | 174.33 | 355.84 | 250.29 | 282.18 | 1,801.71 | 3,001.42 |
Shareholders Equity per Share |
33.66 | 74.44 | (1.87) | 22.93 | 103.44 | 237.58 | 0.33 | 161.21 | 1,099.62 | 2,319.90 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
33.66 | 74.44 | (1.87) | 22.93 | 103.44 | 237.58 | 0.33 | 161.21 | 1,099.62 | 2,319.90 |
Free Cash Flow |
(10.57) | (12.55) | (16.43) | (21.50) | (18.85) | (16.95) | (12.92) | (22.58) | (31.64) | (24.68) |
Working Capital |
(6.89) | (16.96) | (0.24) | 1.77 | 5.53 | 9.36 | (0.03) | 2.54 | 16.96 | 33.92 |
Capital Expenditures |
— | — | — | — | — | — | — | — | (0.04) | (0.05) |
Net Current Asset Value |
(14.10) | (25.38) | (0.24) | 1.77 | 5.53 | 9.36 | (0.03) | 2.54 | 16.92 | 33.86 |
| Other line items | ||||||||||
Quick Ratio |
0.43 | 0.13 | 0.84 | 1.10 | 1.54 | 2.69 | 0.89 | 1.11 | 2.37 | 3.77 |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.84 | 1.75 | 0.76 | 0.68 |
Cash ROIC |
(30.84%) | (49.05%) | (454.42%) | (142.97%) | (126.35%) | (72.31%) | (145.87%) | (217.12%) | (69.90%) | (31.55%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(12.56) | (42.04) | (134.25) | (275.34) | (350.96) | (429.12) | (564.12) | (1,169.96) | (2,025.56) | (1,675.14) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (2.37) | (3.73) |
Average Payables |
10.59 | 7.04 | 1.31 | 1.37 | 2.58 | 2.30 | 1.41 | 1.78 | 2.09 | 3.27 |
Average Assets |
49.23 | 27.46 | 9.09 | 12.74 | 13.13 | 10.54 | 7.25 | 18.54 | 37.46 | 57.88 |
Average Common Equity |
25.28 | 11.00 | 0.78 | 3.67 | 7.47 | 4.70 | 1.56 | 10.13 | 25.63 | 41.41 |
Capex to Sales |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026